By immunohistochemistry for the presence of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu), breast cancers are commonly classified into different molecular subtypes [2]. This evidence concerns the gene PGR and breast cancer.